Combining meta-analysis with multiple imputation for one-step, privacy-protecting estimation of causal treatment effects in multi-site studies
- PMID: 37527843
- DOI: 10.1002/jrsm.1660
Combining meta-analysis with multiple imputation for one-step, privacy-protecting estimation of causal treatment effects in multi-site studies
Abstract
Missing data complicates statistical analyses in multi-site studies, especially when it is not feasible to centrally pool individual-level data across sites. We combined meta-analysis with within-site multiple imputation for one-step estimation of the average causal effect (ACE) of a target population comprised of all individuals from all data-contributing sites within a multi-site distributed data network, without the need for sharing individual-level data to handle missing data. We considered two orders of combination and three choices of weights for meta-analysis, resulting in six approaches. The first three approaches, denoted as RR + metaF, RR + metaR and RR + std, first combined results from imputed data sets within each site using Rubin's rules and then meta-analyzed the combined results across sites using fixed-effect, random-effects and sample-standardization weights, respectively. The last three approaches, denoted as metaF + RR, metaR + RR and std + RR, first meta-analyzed results across sites separately for each imputation and then combined the meta-analysis results using Rubin's rules. Simulation results confirmed very good performance of RR + std and std + RR under various missing completely at random and missing at random settings. A direct application of the inverse-variance weighted meta-analysis based on site-specific ACEs can lead to biased results for the targeted network-wide ACE in the presence of treatment effect heterogeneity by site, demonstrating the need to clearly specify the target population and estimand and properly account for potential site heterogeneity in meta-analyses seeking to draw causal interpretations. An illustration using a large administrative claims database is presented.
Keywords: causal inference; heterogeneity; meta-analysis; multi-site study; multiple imputation; privacy protection.
© 2023 John Wiley & Sons Ltd.
Similar articles
-
Meta-analysis with sample-standardization in multi-site studies.Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):56-59. doi: 10.1002/pds.5527. Epub 2022 Sep 2. Pharmacoepidemiol Drug Saf. 2023. PMID: 35976190
-
Combining multiple imputation and meta-analysis with individual participant data.Stat Med. 2013 Nov 20;32(26):4499-514. doi: 10.1002/sim.5844. Epub 2013 May 24. Stat Med. 2013. PMID: 23703895 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Applications of multiple imputation in medical studies: from AIDS to NHANES.Stat Methods Med Res. 1999 Mar;8(1):17-36. doi: 10.1177/096228029900800103. Stat Methods Med Res. 1999. PMID: 10347858 Review.
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
References
REFERENCES
-
- Toh S, Platt R, Steiner JF, Brown JS. Comparative-effectiveness research in distributed health data networks. Clin Pharmacol Ther. 2011;90(6):883-887.
-
- Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol Drug Saf. 2020;29(S1):3-7.
-
- Hennessy S, Berlin JA. Real-world trends in the evaluation of medical products. Am J Epidemiol. 2023;192(1):1-5.
-
- Ball R, Robb M, Anderson SA, Dal Pan G. The FDA's sentinel initiative-a comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016;99(3):265-268.
-
- Suissa S, Henry D, Caetano P, et al. CNODES: the Canadian network for observational drug effect studies. Open Med. 2012;6(4):e134-e140.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
